|
|
News Breaks
|
| 11:32 EDT |  | VVUS |
| theflyonthewall.com: | Merriman: Victoza approval bodes well for Vivus' Qnexa | | Merriman believes the approval of Novo Nordisk's GLP-1 analog, Victoza, for the treatment of Type 2 diabetes, bodes well for the approval of Vivus' Qnexa. The firm feels the FDA's ability to put the risk/benefit ratio into the proper perspective suggests that there is no "blanket" regulatory bias for or against drugs for diabetes and obesity. :theflyonthewall.com |
|
|
News For VVUS From The Last 14 Days Check below for free stories on VVUS the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
September 8, 2010
|
| 07:00 EDT |  | VVUS |
|
|
September 3, 2010
|
| 12:13 EDT |  | VVUS |
|
|
September 2, 2010
|
| 09:52 EDT |  | VVUS |
|
|
|
|
|
Subscribe for More Information